Vimarsana
Biggest News Aggregation in the World

Page 25 - Research Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Programme Today - Breaking & Trending Today

New $20m initiative in S'pore to develop tools to detect deepfakes and misinformation - Vimarsana News

New $20m initiative in S'pore to develop tools to detect deepfakes and misinformation

The initiative is meant to build online trust and safety. Read more at straitstimes.com.

Singapore to develop tools to detect deepfakes and scams under new $20m initiative - Vimarsana News

Singapore to develop tools to detect deepfakes and scams under new $20m initiative

SINGAPORE - Deepfakes circulating here could be watermarked in the future to alert viewers. Similarly, the same watermarking technology could be used to label trusted content. These are among a new arsenal of detection tools Singapore is developing to tackle the rising scourge of deepfakes and misinformation. The tools will be designed under a new $20 million initiative to build...

Why many children are not completing doses of malaria vaccine - Vimarsana News

Why many children are not completing doses of malaria vaccine

Caregivers who overcome personal barriers are discouraged by the poor attitudes of health providers

Kenya-tested malaria vaccine gets WHO approval - Vimarsana News

Kenya-tested malaria vaccine gets WHO approval

The drug which was tested in three other African countries, becomes the world’s second vaccine to be added to the global prequalified list.

Let's make poor reporting of early phase dose finding clinical trials a thing of the past - Vimarsana News

Let's make poor reporting of early phase dose finding clinical trials a thing of the past

In 2017, I was drafting the first manuscript for a phase I clinical trial. I was familiar with the consolidated standards of reporting trials (Consort) for randomised parallel group trials, so I was surprised by the absence of Consort reporting guidance tailored for early phase dose finding trials. After searching top medical journals for published dose finding trials to assess how they had been reported, I found huge variation in what was being reported and their quality. This presented some big problems for medical research—poor reporting in clinical trials jeopardises patient safety, erod...

Source: bmj.com